Cyclerion Therapeutics Inc
(CYCN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -123,008 | -115,252 | -93,922 | N/A | N/A |
| Depreciation Amortization | 2,700 | 1,528 | 1,745 | N/A | N/A |
| Accounts receivable | -1,474 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -250 | 979 | 392 | N/A | N/A |
| Other Working Capital | -2,289 | 3,788 | 1,465 | N/A | N/A |
| Other Operating Activity | 22,106 | 11,454 | 9,102 | 0 | 0 |
| Operating Cash Flow | $-102,215 | $-97,503 | $-81,218 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,715 | -3,438 | -1,404 | N/A | N/A |
| Investing Cash Flow | $-6,715 | $-3,438 | $-1,404 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 510 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 211,061 | 100,941 | 82,622 | 0 | 0 |
| Financing Cash Flow | $211,571 | $100,941 | $82,622 | $N/A | $N/A |
| Exchange Rate Effect | -20 | N/A | N/A | N/A | N/A |
| End Cash Position | 102,621 | N/A | N/A | N/A | N/A |
| Net Cash Flow | $102,621 | $N/A | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -102,215 | -97,503 | -81,218 | N/A | N/A |
| Capital Expenditure | -6,888 | -3,438 | -1,404 | N/A | N/A |
| Free Cash Flow | -109,103 | -100,941 | -82,622 | 0 | 0 |